Our Team in the News

BioPlan Associates' Ronald Rader

Ron Rader, Sr. Dir. Technical Research: named Editor-in-Chief of Biopharmaceuticals a new peer-reviewed journal from Landes Bioscience. Biopharmaceuticals is the first and only peer-reviewed journal about biopharmaceuticals. Biopharmaceuticals seeks submission of articles concerning biopharmaceuticals and the industry. Please contact the Editor-in-Chief if interested in submitting an article.

BioPlan Associates' Faiz Kermani PhD

Dr Faiz Kermani, Advisory Board: Has helped establish the "Global Health Education Foundation" (GHEF), a not-for-profit healthcare charity to improve educational resources and training for healthcare professionals in developing countries.
At least 1.3 billion people worldwide lack access to the most basic healthcare. The new non-profit foundation, Global Health Education Foundation, aims to tackle such issues. As President of GHEF, Dr Kermani is supporting the R&D focus of the charity to reduce health disparities among developing countries. In particular, the lack of appropriate educational resources and training opportunities for healthcare professionals. http://www.globalhef.org

BioPlan Associates' Managing Director Eric Langer

Eric Langer, Managing Partner: On Advisory Board of “BioProcess Asia Pacific Conference” July 2010 Singapore.
The Biopharmaceutical market in Asia pacific is growing at a rate among the highest in the globe. This is creating a strong need for production of biopharmaceuticals at higher qualities and volumes. Bioprocess AsiaPacific brings together global leaders within biopharmaceutical industry to explore dynamic strategies, benchmark technologies and analyze sustaining the growth of the industry. http://fleminggulf.com/conference/life-science/BioProcessAsiaPacific.


NPD Models that Work

Here's a simple 8-Step Process for New Product Development which works.

Contact BioPlan Associates to help you identify the best new products for your market.

  1. Ideation (Idea generation). The search for new product and market ideas starts with creative idea generation. While these ideally come from your customers, they may also come from your competitors, suppliers, and your internal staff.
  1. Idea Screening (Early-stage evaluation). Here, you screen out ideas that might not fit into your current line or business strategy. You will pre-screen for:
    • Market opportunity (market size, profitability, etc.)
    • Competition (competitive landscape)
    • Production (internal capabilities)
    • Intellectual Property (patent protection, etc.)
    • Channels (distributors, wholesalers, on-line strategies)
    • Financial (available capital, staff, resources) and other factors
  1. Concept Testing (Will your new product solve a customer problem). The company decides whether a product concept will meet customer needs, be profitable, have unique selling points compared with the competitors, etc.
  1. Market Strategy Development (Establish strategies and goals). The company establishes market goals, establishes market mix strategies, evaluates long-term goals, and considers how the product fits its overall goals.
  1. Business Analysis (Market potential). The company reviews its initial sales goals, revenue and profit potential, and break even analysis.
  1. Product Development (Capacity/manufacturing process). The company resolves technical and production issues, considers all aspects of distribution and the sales process.
  1. Market Testing (Marketability testing). The product is beta tested, or sold into test markets, to identify potential problems or areas for redevelopment.
  1. Commercialization (Product launch). The product or service is launched to the full market.

This replicable product development process assures you've considered the major steps in bringing a product to market. Can the product be a success? You'll need to get the word out. Choose your messaging wisely.